GMAB Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $27.72 = $277.2
GMAB Charts
GMAB Prices
View the GMAB historical prices.
52WL $26.32
The 52 Week Low is $26.32 set on Tue, Feb 13, 2024.
52WH $42.72
The 52 Week High is $42.72 set on Mon, Apr 17, 2023. The current price, $27.72, is 0% below the 52 Week High.
ATH $48.90
The All-Time High is $48.90 set on Fri, Sep 3, 2021. The current price, $27.72, is 0% below the All Time High.
52 Week Range
GMAB Dividends
GMAB has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
GMAB Profile
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab is also the creator of Tepezza for thyroid eye disease (partnered with Horizon) and Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), and Tivdak (partnered with Seagen) for cervical cancer. Genmab has several pipeline candidates targeting other oncologic indications.
